Casdin Capital, LLC Q2 2017 Filing
Filed August 14, 2017
Portfolio Value
$270.4B
Holdings
34
Report Date
Q2 2017
Filing Type
13F-HR
All Holdings (34 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —LOXO ONCOLOGY INC | 360,000 | $28.9B | 10.68% | |
| 2 | SG7SAGE THERAPEUTICS INC | 255,000 | $20.3B | 7.51% | |
| 3 | —FOUNDATION MEDICINE INC | 480,000 | $19.1B | 7.06% | |
| 4 | 2L9BLUEPRINT MEDICINES CORP | 275,000 | $13.9B | 5.15% | |
| 5 | EVHEVOLENT HEALTH INC | 520,000 | $13.2B | 4.88% | |
| 6 | AGIOAGIOS PHARMACEUTICALS INC | 255,000 | $13.1B | 4.85% | |
| 7 | GBYSANGAMO THERAPEUTICS INC | 1,400,000 | $12.3B | 4.56% | |
| 8 | CLVSEURCLOVIS ONCOLOGY INC | 130,000 | $12.2B | 4.50% | |
| 9 | XBISPDR SERIES TRUST | 150,000 | $11.6B | 4.28% | Put |
| 10 | —SPARK THERAPEUTICS INC | 170,000 | $10.2B | 3.76% | |
| 11 | GILDGILEAD SCIENCES INC | 135,000 | $9.6B | 3.53% | Call |
| 12 | —KITE PHARMA INC | 90,000 | $9.3B | 3.45% | |
| 13 | ALNYALNYLAM PHARMACEUTICALS INC | 105,000 | $8.4B | 3.10% | |
| 14 | —GENMARK DIAGNOSTICS INC | 685,000 | $8.1B | 3.00% | |
| 15 | —EPIZYME INC | 520,000 | $7.9B | 2.90% | |
| 16 | —AUDENTES THERAPEUTICS INC | 400,000 | $7.7B | 2.83% | |
| 17 | —BLUEBIRD BIO INC | 65,000 | $6.8B | 2.53% | |
| 18 | —TESARO INC | 48,000 | $6.7B | 2.48% | |
| 19 | VYGRVOYAGER THERAPEUTICS INC | 740,000 | $6.6B | 2.45% | |
| 20 | CDXSCODEXIS INC | 1,190,000 | $6.5B | 2.40% | |
| 21 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 215,000 | $5.9B | 2.17% | |
| 22 | ILMNILLUMINA INC | 31,500 | $5.5B | 2.02% | |
| 23 | —MYOKARDIA INC | 395,000 | $5.2B | 1.91% | |
| 24 | —SYROS PHARMACEUTICALS INC | 182,141 | $2.9B | 1.08% | |
| 25 | CTMXCYTOMX THERAPEUTICS INC | 177,500 | $2.8B | 1.02% | |
| 26 | MYGNMYRIAD GENETICS INC | 100,000 | $2.6B | 0.96% | Call |
| 27 | OVIDOVID THERAPEUTICS INC | 221,700 | $2.3B | 0.86% | |
| 28 | JNCEEURJOUNCE THERAPEUTICS INC | 160,000 | $2.2B | 0.83% | |
| 29 | EDITEDITAS MEDICINE INC | 133,333 | $2.2B | 0.83% | |
| 30 | MDRXALLSCRIPTS HEALTHCARE SOLUTN | 150,000 | $1.9B | 0.71% | Call |
| 31 | FATEFATE THERAPEUTICS INC | 550,000 | $1.8B | 0.66% | |
| 32 | AMRSEURAMYRIS INC | 500,000 | $1.6B | 0.59% | |
| 33 | PACBPACIFIC BIOSCIENCES CALIF IN | 300,000 | $1.1B | 0.40% | |
| 34 | —CURIS INC | 85,000 | $161.0M | 0.06% |